| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |